New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 10, 2014
15:12 EDTOREXOrexigen Therapeutics volatility elevated into PDUFA
Orexigen Therapeutics June call option implied volatility is at 154, July is at 109, October is at 84; compared to its 26-week average of 82 according to Track Data, suggesting large movement into the PDUFA goal date of June 11 for Contrave.
News For OREX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 19, 2014
09:28 EDTOREXOn The Fly: Pre-market Movers
Subscribe for More Information
07:21 EDTOREXOrexigen Mysimba receives positive CHMP opinion
Subscribe for More Information
07:20 EDTOREXOrexigen weight loss drug recommended in Europe
The European Medicines Agency's Committee for Medicinal Products for Human Use recommended granting a marketing authorization for Mysimba for weight management of overweight or obese adults. The medicine is recommended for use in addition to a reduced-calorie diet and physical activity. Mysimba is made by Orexigen.
December 15, 2014
10:10 EDTOREXHigh option volume stocks:
High option volume stocks: RVBD AGCO FRO CRUS UBNT LH PAY PETM OREX KOS

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use